Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells

By Lu Y.   Zi X.   Zhao Y.   Pollak M.  

Biochemical and Biophysical Research Communications, Vol. 313, Iss. 3, 2004-01 ,pp. : 709-715

Elsevier

Access to resources Recommend Favorite

Epidermal Growth Factor Stimulates 3-Hydroxy-3-Methylglutaryl-coenzyme A Reductase Expression via the ErbB-2 Pathway in Human Breast Adenocarcinoma Cells

By Asslan R.   Pradines A.   Pratx C.   Allal C.   Favre G.   Le Gaillard F.  

Biochemical and Biophysical Research Communications, Vol. 260, Iss. 3, 1999-07 ,pp. : 699-706

Elsevier

Access to resources Recommend Favorite

Enhanced Drug Resistance in Cells Coexpressing ErbB2 with EGF Receptor or ErbB3

By Chen X.   Yeung T.K.   Wang Z.  

Biochemical and Biophysical Research Communications, Vol. 277, Iss. 3, 2000-11 ,pp. : 757-763

Elsevier

Access to resources Recommend Favorite

Inhibition of the erbB-2 Tyrosine Kinase Receptor in Breast Cancer Cells by Phosphoromonothioate and Phosphorodithioate Antisense Oligonucleotides

By Vaughn James P.   Demirdji Samuel   Mills Jeffrey K.   Caruthers Marvin H.   Iglehart J. Dirk   Marks Jeffrey R.  

Nucleic Acids Research, Vol. 24, Iss. 22, 1996-11 ,pp. : 4558-4564

Oxford University Press

Access to resources Recommend Favorite

Signal Transduction-Mediated Regulation of Urokinase Gene Expression in Human Prostate Cancer

By Eandi J.A.   Yang J.C.   Evans C.P.  

Biochemical and Biophysical Research Communications, Vol. 288, Iss. 3, 2001-11 ,pp. : 521-527

Elsevier

Access to resources Recommend Favorite